Table 3 Preoperative characteristics of the whole cohort and unadjusted odds ratios for initial poor graft function
Whole cohort (n = 183) | No IPGF (n = 141) | IPGF (n = 42) | OR for IPGF (95%CI) | P value | |
|---|---|---|---|---|---|
Donor | |||||
Age (years) | 34.0 [28.8–37.1] | 32.7 [28.1–36.8] | 34.7 [31.1–38.5] | 1.06 (1.01–1.12) | .03 |
Sex (female) | 85 (46.4) | 65 (46.1) | 20 (47.6) | 1.06 (0.53–2.12) | .86 |
Receiver | |||||
Age (years) | 1.6 [0.9–2.8] | 1.3 [0.8–2.3] | 2.3 [1.0–4.9] | 1.13 (1.01–1.26) | .04 |
Sex (female) | 103 (56.3) | 81 (57.4) | 22 (52.4) | 1.22 (0.62–2.45) | .56 |
Weight (kg) | 9.6 [7.6–14.0] | 9.2 [7.4–12.8] | 12.7 [7.8–17.8] | 1.04 (0.99–1.09) | .08 |
Liver pathology | |||||
Biliary atresia | 118 (64.5) | 95 (67.4) | 23 (54.8) | 1.00 (reference) | |
Other | 65 (35.5) | 46 (32.6) | 19 (45.24) | 7.71 (0.85–3.44) | .14 |
Cirrhosis | 157 (85.8) | 122 (86.5) | 35 (83.3) | 0.78 (0.30–2.00) | .60 |
ASAT (U/L) | 155 [85–231] | 171 [95–221] | 125 [82–228] | 1.00 (0.99–1.00) | .21 |
ALAT (U/L) | 89 [49–131] | 94 [52–134] | 80 [45–125] | 1.00 (0.99–1.00) | .42 |
Bilirubin (mg/dL) | 15.1 [2.8–20.3] | 15.1 [2.9–21.1] | 14.3 [2.7–23.1] | 1.00 (0.97–1.03) | .79 |
INR | 1.26 [1.09–1.60] | 1.26 [1.09–1.61] | 1.26 [1.08–1.56] | 0.83 (0.45–1.53) | .56 |
Urea (mg/dL) | 16 [13–22] | 16 [12–21] | 16 [13–23] | 1.00 (0.96–1.04) | .97 |
Creatinine (mg/dL) | 0.25 [0.19–0.33] | 0.24 [0.17–0.32] | 0.29 [0.23–0.36] | 22.02 (1.25–399.21) | .03 |
Albumin (g/L) | 32 [29–38] | 32 [28–37] | 35 [32–39] | 1.04 (0.99–1.09) | .08 |
NLR | 1.0 [0.6–1.5] | 0.9 [0.6–1.4] | 1.2 [0.7–2.1] | 1.35 (1.04–1.75) | .03 |